Protein studies may lead to new Alzheimer's test

Main Category: Alzheimer's / Dementia
Article Date: 20 Apr 2005 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


A study appearing in an upcoming issue of the Journal of Alzheimer's Disease (http://www.j-alz.com), published by IOS Press, entitled "Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease," may lead to a new test for diagnosing the devastating illness. About 4 million Americans suffer from Alzheimer's disease, the most common form of dementia, characterized by memory loss and an inability to use language.

"The study identified 40 times more proteins in human spinal fluid than previously known," said Drs. Thomas Montine and Jing Zhang, co-authors of the study and neuropathologists at Harborview Medical Center and the University of Washington. Montine is a UW professor of neuropathology and Zhang is a UW assistant professor of pathology. "As a result, we hope to be able to develop a much more thorough and robust test for diagnosing and predicting the progression of Alzheimer's disease," said Montine.

The study employed a proteomic method developed at the University of Washington and the Institute for Systems Biology in Seattle. It identified more than 400 proteins in human spinal fluid, up to 40 times more proteins than identified by previous research models. On average, one of every five proteins identified was substantially changed in patients with Alzheimer's disease compared to older people without neurologic disease. This roster of changed proteins will serve as a platform to develop specific biomarker panels for Alzheimer's disease and other geriatric dementias.

"The implications of having more rigorous tests to diagnosis Alzheimer's disease, Parkinson's disease and dementia are enormous and could have a huge impact," said Montine.

Harborview Medical Center is owned by King County and managed by the University of Washington.

Contact: Susan Gregg-Hanson,
Harborview Medical Center
sghanson@u.washington.edu
206-731-4097
University of Washington
http://www.washington.edu

Article adapted by Medical News Today from original press release.
Visit our alzheimer's / dementia section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Susan Gregg-Hanson. "Protein studies may lead to new Alzheimer's test." Medical News Today. MediLexicon, Intl., 20 Apr. 2005. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/23088.php>

APA
Susan Gregg-Hanson. (2005, April 20). "Protein studies may lead to new Alzheimer's test." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/23088.php.

Please note: If no author information is provided, the source is cited instead.


Alzheimer's / Dementia

What Is Alzheimer's Disease?

Alzheimer's disease is a progressive neurologic disease of the brain leading to the irreversible loss of neurons and the loss of intellectual abilities, including memory and reasoning. Read more...

What is Dementia?

The word dementia comes from the Latin de meaning "apart" and mens from the genitive mentis meaning "mind". Dementia is the progressive deterioration in cognitive function - the ability to process thought (intelligence). Read more...

Most Popular Articles



Follow Our Alzheimer's News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Alzheimer's / Dementia Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »